0.3000
0.0000
(0.00%)
At close: April 8 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
191.3650
3.5490
73.0090
246.0320
1,661.2780
Cost of Revenue
105.2550
--
22.5520
127.6690
1,304.9460
Gross Profit
86.1100
3.5490
50.4570
118.3630
356.3320
Operating Expense
3,378.9440
1,427.7170
4,147.0140
11,153.6890
7,246.9050
Operating Income
-3,292.8340
-1,424.1680
-4,096.5570
-11,035.3260
-6,890.5730
Net Non Operating Interest Income Expense
-1,651.2100
-569.7650
-556.8270
-5,014.1940
-1,705.1650
Other Income Expense
--
-44.5250
33.8180
-961.0280
-1,971.3510
Pretax Income
-4,988.4960
-2,038.4580
-4,619.5660
-17,010.5480
-10,567.0890
Net Income Common Stockholders
-4,988.4960
-2,038.4580
-4,646.0550
-17,379.7700
-10,567.0890
Diluted NI Available to Com Stockholders
-4,988.4960
-2,038.4580
-4,646.0550
-17,379.7700
-10,567.0890
Basic EPS
-0.04
-0.07
-0.23
-1.38
-1.40
Diluted EPS
-0.04
-0.07
-0.23
-1.38
-1.40
Basic Average Shares
70,944.9270
28,436.0630
20,339.3910
12,578.2710
7,521.2870
Diluted Average Shares
70,944.9270
28,436.0630
20,339.3910
12,578.2710
7,521.2870
Total Operating Income as Reported
-3,292.8340
-1,424.1680
-4,096.5570
-11,035.3260
-6,890.5730
Total Expenses
3,484.1990
1,427.7170
4,169.5660
11,281.3580
8,551.8510
Net Income from Continuing & Discontinued Operation
-4,988.4960
-2,038.4580
-4,646.0550
-17,379.7700
-10,567.0890
Normalized Income
-4,943.9710
-1,993.9330
-4,653.3840
-16,049.5200
-8,595.7380
Interest Expense
497.2100
569.7650
556.8270
5,014.1940
1,705.1650
Net Interest Income
-1,651.2100
-569.7650
-556.8270
-5,014.1940
-1,705.1650
EBIT
-4,491.2860
-1,468.6930
-4,062.7390
-11,996.3540
-8,861.9240
EBITDA
-4,481.4800
-1,458.7850
-4,056.7220
-11,983.7730
-8,861.6520
Reconciled Cost of Revenue
105.2550
--
22.5520
127.6690
1,304.9460
Reconciled Depreciation
9.8060
9.9080
6.0170
12.5810
0.2720
Net Income from Continuing Operation Net Minority Interest
-4,988.4960
-2,038.4580
-4,619.5660
-17,010.5480
-10,567.0890
Total Unusual Items Excluding Goodwill
-44.5250
-44.5250
33.8180
-961.0280
-1,971.3510
Total Unusual Items
-44.5250
-44.5250
33.8180
-961.0280
-1,971.3510
Normalized EBITDA
-4,436.9550
-1,414.2600
-4,090.5400
-11,022.7450
-6,890.3010
12/31/2020 - 3/26/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade